SCHEMBL5210469

SCHEMBL5210469

COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2C(C)(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PSEN1 P49768 2/20 0.51
PSEN2 P49810 2/20 0.51
APH1B Q8WW43 2/20 0.51
NCSTN Q92542 2/20 0.51
APH1A Q96BI3 2/20 0.51
PSENEN Q9NZ42 2/20 0.51
LMNA P02545 3/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 1/20 0.45
CA1 P00915 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
BDKRB1 P46663 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5213143 1.00 GAA (0.53) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5213387 1.00 GAA (0.53) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5210459 0.88 GAA (0.44) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5212973 0.85 ESR1 (0.46) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5212982 0.85 ESR1 (0.46) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5215097 0.85 ESR1 (0.46) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL4953593 0.84 PSEN1 (0.54) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL4953604 0.84 PSEN1 (0.54) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5213948 0.84 PSEN1 (0.54) GAANPSR1L3MBTL1PSEN1PSEN2
SCHEMBL5211899 0.83 LMNA (0.53) GAANPSR1L3MBTL1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567502-B1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES WYETH CORP (US) 2007-08-22 EP disclosed
EP-1567502-A1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES Wyeth (US) 2005-08-31 EP disclosed
US-6894061-B2 Substituted dihydrophenanthridinesulfonamides WYETH (US) 2005-05-17 US disclosed
US-20040167155-A1 Substituted dihydrophenanthridinesulfonamides WYETH 2004-08-26 US disclosed
WO-2004050631-A1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES WYETH (US) 2004-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167155-A1 Substituted dihydrophenanthridinesulfonamides TNNT2, TNNI3, SIRT5 GAA 2854/4885NPSR1 1280/4885L3MBTL1 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.